Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 26;187(26):7433-7449.e20.
doi: 10.1016/j.cell.2024.11.001. Epub 2024 Dec 3.

Structure-guided design of a peripherally restricted chemogenetic system

Affiliations

Structure-guided design of a peripherally restricted chemogenetic system

Hye Jin Kang et al. Cell. .

Abstract

Designer receptors exclusively activated by designer drugs (DREADDs) are chemogenetic tools for remotely controlling cellular signaling, neural activity, behavior, and physiology. Using a structure-guided approach, we provide a peripherally restricted Gi-DREADD, hydroxycarboxylic acid receptor DREADD (HCAD), whose native receptor is minimally expressed in the brain, and a chemical actuator that does not cross the blood-brain barrier (BBB). This was accomplished by combined mutagenesis, analoging via an ultra-large make-on-demand library, structural determination of the designed DREADD receptor via cryoelectron microscopy (cryo-EM), and validation of HCAD function. Expression and activation of HCAD in dorsal root ganglion (DRG) neurons inhibit action potential (AP) firing and reduce both acute and tissue-injury-induced inflammatory pain. The HCAD chemogenetic system expands the possibilities for studying numerous peripheral systems with little adverse effects on the central nervous system (CNS). The structure-guided approach used to generate HCAD also has the potential to accelerate the development of emerging chemogenetic tools for basic and translational sciences.

Keywords: GPCR; chemogenetics; peripheral nervous system.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. Armbruster BN, Li X, Pausch MH, Herlitze S, and Roth BL (2007). Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl. Acad. Sci. USA 104, 5163–5168. 10.1073/pnas.0700293104. - DOI - PMC - PubMed
    1. Boyden ES, Zhang F, Bamberg E, Nagel G, and Deisseroth K (2005). Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci 8, 1263–1268. 10.1038/nn1525. - DOI - PubMed
    1. Bishop AC, Shah K, Liu Y, Witucki L, Kung C, and Shokat KM (1998). Design of allele-specific inhibitors to probe protein kinase signaling. Curr. Biol 8, 257–266. 10.1016/s0960-9822(98)70198-8. - DOI - PubMed
    1. Coward P, Wada HG, Falk MS, Chan SD, Meng F, Akil H, and Conklin BR (1998). Controlling signaling with a specifically designed Gi-coupled receptor. Proc. Natl. Acad. Sci. USA 95, 352–357. 10.1073/pnas.95.1.352. - DOI - PMC - PubMed
    1. Kang H (2023). Chemogenetics for cell-type-specific modulation of signalling and neuronal activity. Nat. Rev. Methods Primers 3, 94. 10.1038/s43586-023-00285-0. - DOI

LinkOut - more resources